The cost-effective use of 18F-FDG PET in the presurgical evaluation of medically refractory focal epilepsy

Journal of Nuclear Medicine

Volumn 49, Issue 6, 2008, Pages 931-937

  O'Brien, Terence J ^a,e   Miles, Ken ^b   Ware, Robert ^c   Cook, Mark J ^d   Binns, David S ^c   Hicks, Rodney J ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Decision tree analysis; Epilepsy; Epilepsy surgery; FDG; Neurology; PET

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; ETHYL CYSTEINATE DIETHYLESTER TC 99M; FLUORODEOXYGLUCOSE F 18; TRACER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC ACCURACY; DRUG COST; ELECTROENCEPHALOGRAM; FOCAL EPILEPSY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; AUSTRALIA; CHRONIC DISEASE; COHORT ANALYSIS; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MALE; MIDDLE AGED; PREOPERATIVE CARE; PREVALENCE; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CHRONIC DISEASE; COHORT STUDIES; COST-BENEFIT ANALYSIS; EPILEPSIES, PARTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PREVALENCE; RADIOPHARMACEUTICALS;

EID: 44849086449     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.048207     Document Type: Article

References (40)

1. Lowe AJ, David E, Kilpatrick CJ, et al. Epilepsy surgery for pathologically proven hippocampal sclerosis provides long-term seizure control and improved quality of life. Epilepsia. 2004;45:237-242.
2. McIntosh AM, Kalnins RM, Mitchell LA, Fabinyi GC, Briellmann RS, Berkovic SF. Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain. 2004;127:2018-2030.
3. Wiebe S, Blume WT, Girvin JP, Eliasziw M. Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, control trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311-318.
4. Kilpatrick C, Cook M, Kaye A, Murphy M, Matkovic Z. Non-invasive investigations successfully select patients for temporal lobe surgery. J Neurol Neurosurg Psychiatry. 1997;63:327-333.
5. Engel J Jr, Kuhl D, Phelps M. Interictal cerebral glucose metabolism in partial epilepsy and its relationship to EEG changes. Ann Neurol. 1982;12:510-517.
6. 18F]fluorodeoxyglucose positron emission tomography in refractory partial seizures. Ann Neurol. 1983;14:429-437.
7. Ho SS, Berkovic SF, Berlangieri SU, et al. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy. Ann Neurol. 1995;37:738-745.
8. Henry TR. PET: cerebral blood flow and glucose metabolism - presurgical localization. In: Henry TR, Duncan JS, Berkovic SF, eds. Functional Imaging in the Epilepsies. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:105-120.
9. O'Brien TJ, Hicks RJ, Ware R, Binns DS, Murphy M, Cook MJ. The utility of a 3-D, large-field-of-view, PENN-PET scanner in the presurgical evaluation of partial epilepsy. J Nucl Med. 2001;42:1158-1165.
10. Vinton AB, Carne R, Hicks RJ, et al. The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain. 2007;130:548-560.
11. Theodore WH, Sato S, Kufta C, Balish MB, Bromfield EB, Leiderman DB. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol. 1992;32:789-794.
12. Radtke RA, Hanson MW, Hoffman JM, et al. Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. Neurology. 1993;43:1088-1092.
13. Wong CY, Geller EB, Chen EQ, et al. Outcome of temporal lobe epilepsy surgery predicted by statistical parametric PET imaging. J Nucl Med. 1996;37:1094-1100.
14. Manno EM, Sperling MR, Ding X, et al. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Neurology. 1994;44:2331-2336.
15. Koutroumanidis M, Hennessy MJ, Seed PT, et al. Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy. Neurology. 2000;54:1811-1821.
16. Newberg AB, Alavi A, Berlin J, Mozley PD, O'Connor M, Sperling M. Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures. J Nucl Med. 2000;41:1964-1968.
17. Choi JY, Kim SJ, Hong SB, et al. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Eur J Nucl Med Mol Imaging. 2003;30:581-587.
18. Yun CH, Lee SK, Lee SY, Kim KK, Jeong SW, Chung CK. Prognostic factors in neocortical epilepsy surgery: multivariate analysis. Epilepsia. 2006;47:574-579.
19. Lee SK, Lee SY, Kim KK, Hong KS, Lee DS, Chung CK. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol. 2005;58:525-532.
20. Engel J Jr, Henry TR, Swartz BE. Positron emission tomography in frontal lobe epilepsy. Adv Neurol. 1995;66:223-238.
21. 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J Nucl Med. 1999;40:737-746.
22. Powers WJ, Berg L, Perlmutter JS, Raichle ME. Technology assessment revisited: does positron emission tomography have proven clinical efficacy? Neurology. 1991;41:1339-1340.
23. Wieshmann UC, Woermann FG, Lemieux L, et al. Development of hippocampal atrophy: a serial magnetic resonance imaging study in a patient who developed epilepsy after generalized status epilepticus. Epilepsia. 1997;38:1238-1241.
24. Sadzot B. Neuroimaging in epilepsy: is there a future for positron emission tomography. Epilepsia. 1996;37:511-514.
25. Castillo M. Imaging intractable epilepsy: how many tests are enough? AJNR. 1999;20:534-535.
26. Medicare Services Advisory Committee. Positron Emission Tomography (PET) for Epilepsy. Canberra, Australia: Medicare Services Advisory Committee, Department of Health and Aged Care; 2004.
27. Singer ME, Applegate KE. Cost-effectiveness analysis in radiology. Radiology. 2001;219:611-620.
28. Cook M, Stevens JM. Imaging in epilepsy. In: Hopkins A, Shorvon S, Cascino G, eds. Epilepsy. 2nd ed. London, U.K.: Chapman & Hall; 1995:143-169.
29. Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM. Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain. 1992;115:1001-1015.
30. O'Brien TJ, So EL, Mullan BP, et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology. 1998;50:445-454.
31. O'Brien TJ, O'Connor MK, Mullan BP, et al. Subtraction ictal SPECT coregistered to MRI in partial epilepsy: description and technical validation of the method with phantom and patient studies. Nucl Med Commun. 1998;19:31-45.
32. O'Brien TJ, So EL, Mullan BP, et al. Detection of localized hypoperfusion by subtraction SPECT co-registered to MRI (SISCOM) improves the sensitivity and specificity of postictal SPECT in intractable partial epilepsy. Neurology. 1999;52:137-146.
33. Kaiboriboon K, Lowe VJ, Chantarujikapong SI, Hogan RE. The usefulness of subtraction ictal SPECT coregistered to MRI in single- and dual-headed SPECT cameras in partial epilepsy. Epilepsia. 2002;43:408-414.
34. O'Brien TJ, So EL, Cascino GD, et al. Subtraction SPECT coregistered to MRI in malformations of cortical development: localization of the epileptogenic zone in epilepsy surgery candidates. Epilepsia. 2004;45:367-376.
35. Engel J Jr, Van Ness P, Rasmussen T, Ojemann L. Outcome with respect to epileptic seizures. In: Engel J, ed. Surgical Treatment of the Epilepsies. New York, NY: Raven Press; 1993:609-621.
36. Won HJ, Chang KH, Cheon JE, et al. Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. AJNR. 1999;20:593-599.
37. Commonwealth Department of Health and Family Services. Development of the Australian Refined Diagnosis Related Groups (AR-DRG) Classification Version 4. Canberra, ACT, Australia: The Commonwealth of Australia; 1998.
38. Sunshine J, McNeil B. Rapid method for rigorous assessment of radiologic imaging technologies. Radiology. 1997;202:549-557.
39. Bien CG, Kurthen M, Baron K, et al. Long-term seizure outcome and antiepileptic drug treatment in surgically treated temporal lobe epilepsy patients: a controlled study. Epilepsia. 2001;42:1416-1421.
40. Kilpatrick CJ, O'Brien TJ, Matkovic Z, Cook M, Kaye A. Preoperative evaluation for temporal lobe surgery. J Clin Neurosci. 2003;10:535-539.